Glucagon Ready-to-Use for the Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D
Status:
Completed
Trial end date:
2020-03-23
Target enrollment:
Participant gender:
Summary
This study is a randomized, placebo-controlled, double-blind, two-treatment, two-period,
crossover comparison in a clinical research center (CRC) setting, followed by a randomized,
placebo-controlled, partially double-blinded, 3-arm parallel comparison in an outpatient
setting to evaluate the preliminary efficacy and safety of Glucagon Ready-to-Use (RTU) to
prevent exercise-induced hypoglycemia (EIH) in adults with Type 1 diabetes mellitus (T1D),
who perform regular, moderate-to-high intensity aerobic exercise.